• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, September 12, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Using a pig model to study chronic diseases may help minimize drug failure rate

Bioengineer by Bioengineer
July 20, 2017
in Science News
Reading Time: 4 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Scientists may be able to minimize the failure rate of drugs for diseases linked to high-calorie diets, such as colon cancer and type 2 diabetes, if they test treatments using a pig model, according to an international team of researchers.

In a study, researchers found that pigs, which have gut bacterial profiles and immune systems similar to humans, also maintain two distinct colonic stem cell populations – ASCL-2 and BMI-1. Mice lack colonic BMI-1 stem cells that play a critical role in how colon cancer forms – or carcinogenesis – and how material passes through the cell lining of the intestinal wall – or gut permeability.

"Seven out of ten deaths in the United States are due to chronic conditions," said Jairam K.P. Vanamala, associate professor of food sciences, Penn State. "And, yet, we have a high failure rate for drugs and treatments in studies looking to alleviate those conditions. Treatments that work in mice, do not always work well in humans. We show that a pig model may be an alternative that can help lead to better treatments and food-based prevention and therapeutic strategies."

The researchers, who released their findings in Cancer Prevention Research Journal, published by the American Association of Cancer Research, used a visualization technique – immunofluorescence – to identify stem cells in the colon of pigs that were fed either a high calorie diet or a standard diet. They observed two types of stem cells – ASCL-2 positive and BMI-1 positive – in the pig colon, similar to the human system.

"Mice models will continue to be important to study under certain conditions," said Vanamala, who is also a faculty member at the Penn State Hershey Cancer Institute. "But, what we found is that the pig model has both a microbiome that is closer to the human microbiome and the intestinal physiology is, also, similar to humans."

The gut microbiome refers to the 30-50 trillion or so bacteria that dwell in the gut.

According to the researchers, stem cells, which can generate all types of intestinal cells, are typically located deep within tube-like crevices – called crypts. However, when cells at the ends of the crypt are damaged, stem cells move up the crypt to help repair the damage. In pigs that consumed a high calorie diet, the researchers found that the stem cells moved out of the protected base of the crypt and potentially exposed themselves to similar damage.

In the case of pigs and humans, when cells are damaged, most likely only BMI-1 stem cells are activated and move up the crypt, say the researchers.

"So, if we are studying colon crypts and looking at, for example, how cancer develops in mice, we are only taking one type of stem cells into the equation, not the interplay of both ASCL-2 and BMI-1," said Vanamala. "We need to see how these stem cells are both working together to heal, or how they are damaged that leads to the development of colon cancer."

Vanamala suggests that BMI-1 stem cells may become cancerous if exposed while moving up the crypt to heal cells and are damaged by inflammation and toxins produced by eating a high-calorie diet.

"A high calorie diet means you may not be taking in a lot of fiber, which is an important food for the gut bacteria, and these gut bacteria devoid of any fiber may start eating away at the mucous and also start producing toxins, which causes inflammation to set in," said Vanamala. "The stem cells that are working to repair this damage, then, are starting to move up the crypt toward the lumen where they may get exposed to toxins. Once they get damaged, the stem cell – because it lives a long time – can potentially become cancerous."

Vanamala added that one of the advantages of having human-relevant and agriculturally important animals model is that research at the intersection of agricultural and medical research can be strengthened to develop safe, affordable and evidence-based food approaches to counter the global epidemic of chronic diseases. As an example, he cited his previous research on baked purple potatoes that have compounds that help suppress chronic intestinal inflammation elevated from a high-calorie diet and stem cell proliferation, which are linked to both colitis and colon cancer.

For the current study, the researchers fed eight pigs a high-calorie diet, which has 23 percent fat, and fed the control group of eight pigs a standard diet with 5 percent fat during a 13-week period.

###

Vanamala worked with Venkata Charapelli, doctoral candidate, and Sridhar Radhakrishnan, former post-doctoral scholar, both in the department of food science; Lavanya Reddivari, assistant professor and research associate in the department of plant science; Vijay-Kumar Matam, assistant professor and Xia Xiao, graduate student in the department of nutritional sciences; Qunhua Li, assistant professor and Frank Shen, graduate student, both in the department of statistics, all of Penn State; Elisabeth Eriksson, doctoral candidate in biotechnology, applied nutrition and food chemistry, Lund University, Sweden; Vadiraja B. Bhat, senior applications scientist, Agilent Technologies; Sung Woo Kim, professor of animal science, University of North Carolina, and Rob Knight, professor of pediatrics, with an additional appointment in computer science, University of California

Approximately 40 percent of the cost of funding this work came from the United States Department of Agriculture.

Media Contact

Matt Swayne
[email protected]
814-865-9481
@penn_state

http://live.psu.edu

Share12Tweet8Share2ShareShareShare2

Related Posts

Gastroschisis Rates Shift Pre- and Post-COVID

September 12, 2025
blank

Non-GMO Yeast Boosts Glutathione via Acrolein Resistance

September 12, 2025

East Palestine Train Derailment: Chemical Hazard Insights

September 12, 2025

Microemulsions Enhance Resistance in Mycoplasma gallisepticum

September 12, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    152 shares
    Share 61 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • Physicists Develop Visible Time Crystal for the First Time

    64 shares
    Share 26 Tweet 16
  • A Laser-Free Alternative to LASIK: Exploring New Vision Correction Methods

    48 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Gastroschisis Rates Shift Pre- and Post-COVID

Non-GMO Yeast Boosts Glutathione via Acrolein Resistance

East Palestine Train Derailment: Chemical Hazard Insights

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.